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After development in the BM, NK cells are re-
leased into circulation and are found in large 
numbers in the spleen and liver. Recent studies 
have also highlighted the presence of NK cells 
within LNs (Martín-Fontecha et al., 2004; 
Chen et al., 2005; Bajénoff et al., 2006; Garrod 
et al., 2007; Walzer et al., 2007a), accounting 
for 0.5% of cells in mouse LNs and 5% in 
human LNs (Grégoire et al., 2007). After im-
munization or infection, NK cell numbers can 
increase rapidly within draining LNs (Martín-
Fontecha  et  al.,  2004;  Lucas  et  al.,  2007; 
Gustafsson et al., 2008; Watt et al., 2008). Ac-
cumulating evidence suggests that NK cells help 
shape the adaptive immune response emerging 
within a responding lymphoid tissue (Martín-
Fontecha  et  al.,  2004;  Bajénoff  et  al.,  2006; 
Kassim et al., 2009). LNs and spleen are also 
likely to be early sites of NK encounter with in-
flammatory stimuli presented, for example, by 
dendritic cells. A recent study has provided evi-
dence that NK cells can be primed in draining 
LNs before returning to the circulation with 
enhanced effector function (Lucas et al., 2007). 
Moreover, several recent studies have identi-
fied requirements for NK cell entry into LNs 
(Martín-Fontecha et al., 2004; Chen et al., 2005; 
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During a screen for ethylnitrosourea-induced mutations in mice affecting blood natural 
killer (NK) cells, we identified a strain, designated Duane, in which NK cells were reduced in 
blood and spleen but increased in lymph nodes (LNs) and bone marrow (BM). The accumu-
lation of NK cells in LNs reflected a decreased ability to exit into lymph. This strain carries 
a point mutation within Tbx21 (T-bet), which generates a defective protein. Duane NK cells 
have a 30-fold deficiency in sphingosine-1-phosphate receptor 5 (S1P5) transcript levels, 
and S1P5-deficient mice exhibit an egress defect similar to Duane. Chromatin immunopre-
cipitation confirms binding of T-bet to the S1pr5 locus. S1P-deficient mice exhibit a more 
severe NK cell egress block, and the FTY720-sensitive S1P1 also plays a role in NK cell 
egress from LNs. S1P5 is not inhibited by CD69, a property that may facilitate trafficking of 
activated NK cells to effector sites. Finally, the accumulation of NK cells within BM of 
S1P-deficient mice was associated with reduced numbers in BM sinusoids, suggesting a role 
for S1P in BM egress. In summary, these findings identify S1P5 as a T-bet–induced gene 
that is required for NK cell egress from LNs and BM.
© 2009 Jenne et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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to have the CD27hiKLRG1lo phenotype typical of immature 
NK cells (Fig. 1 B). Duane had a near complete absence of 
mature iNKT cells (Fig. S1 A).
To determine if the NK cell accumulation in peripheral 
LNs was cell intrinsic, mixed BM chimeras were generated. 
In these mice, a lower percentage of Duane NK cells was ob-
served in blood and spleen as compared with wild-type NK 
cells, whereas there was a relative accumulation of Duane NK 
cells in peripheral LNs (Fig. 2 A). The distribution of Duane 
and wild-type B cells was examined as a control and was 
equivalent in all sites (Fig. 2 A). Analysis of the lymph from 
these mice revealed an underrepresentation of Duane NK 
cells, suggesting that the LN accumulation was caused by a 
failure of these cells to egress (Fig. 2 A). When mixed BM 
chimeras were treated with 4 integrin, L integrin, and 
L-selectin blocking antibodies to prevent NK cell and lym-
phocyte entry into LNs (von Andrian and Mempel, 2003; 
Bajénoff et al., 2006; Pham et al., 2008), and the extent of 
decay in LN cell numbers was measured after 40 h, an in-
crease in the percentage of Duane NK cells was observed 
(Fig. 2 A). This finding was consistent with a reduction in the 
ability of Duane NK cells to exit LNs. In another test of traf-
ficking behavior, wild-type and Duane splenocytes were each 
transferred into wild-type B6 recipients, and 24 h later the ra-
tio of donor NK cells in the LN versus spleen was calculated. 
A greater fraction of Duane NK cells was found in the LNs as 
compared with wild-type NK cells, consistent with a defect 
in Duane NK cell egress from peripheral LNs (Fig. 2 B).
Identification of the Duane mutation
Mapping the causative genetic lesion in Duane was achieved 
by crossing an affected Duane mouse onto a wild-type 
C57BL/10 mouse, followed by intercrossing these F1 off-
spring and screening for the Duane phenotype. The seven 
most clearly affected and eight clearly unaffected mice were 
selected for the initial genome scan. Mapping was performed 
as previously described (Nelms and Goodnow, 2001) by us-
ing a panel of 80 Amplifluor assays that can distinguish single 
nucleotide polymorphisms (SNPs) between C57BL/6 and 
C57BL/10. The only clear linkage was for markers on the 
distal part of chromosome 11, and all mice were typed for 
these markers individually (Fig. S2 A). Because of a lack of 
markers that are capable of distinguishing between C57BL/6 
and C57BL/10 in the region distal to 79 Mbp on chromo-
some 11, we set up a second round of mapping by crossing 
an affected Duane mouse with a wild-type CBA/J mouse, 
followed by backcrossing to another affected Duane mouse. 
The resulting N2 mice were tested for the Duane pheno-
type  and  genotyped  for  SNPs  distinguishing  CBA/J  and 
C57BL/6 genomes on distal chromosome 11. This strategy 
confirmed linkage to a region between 89.3 and 116.1 Mbp 
on chromosome 11 (Fig. S2 B).
A search of the Mouse Genome Database (available at 
http://www.informatics.jax.org/; Bult et al., 2008) for genes 
in this interval identified Tbx21 as a likely candidate. Se-
quencing the genomic DNA corresponding to the gene 
Bajénoff et al., 2006; Lucas et al., 2007); however, less is un-
derstood about how they return to circulation.
T cell egress from thymus, and T and B cell egress from 
peripheral  lymphoid  organs  depends  on  sphingosine-1-
phosphate (S1P) and S1P receptor 1 (S1P1; Allende et al., 
2004; Matloubian et al., 2004; Pappu et al., 2007). In con-
trast, S1P1 and S1P deficiency have not been found to block 
B cell egress from BM (Matloubian et al., 2004; Pappu et al., 
2007). FTY720, a small molecule that can down-modulate 
S1P1, is also effective in preventing T and B cell egress from 
thymus and LNs (Mandala et al., 2002; Gräler and Goetzl, 
2004; Matloubian et al., 2004). However, FTY720 treat-
ment does not deplete NK cells from circulation in mice or 
humans (Vaessen et al., 2006; Walzer et al., 2007b). NK 
cells selectively express S1P5, and in mice deficient in this 
receptor, NK cell distribution was altered, with reduced NK 
cell numbers in blood and spleen and increased numbers in 
LNs and BM (Walzer et al., 2007b). This work established a 
role for S1P5 in NK cell recirculation; however, S1P5’s role 
in egress was not defined.
T-bet is a T-box–containing transcription factor that is re-
quired for Th1 cell development and also functions in the 
generation of effector CD8+ T cells and in B cells for switch-
ing to IgG2a (Szabo et al., 2000; Peng et al., 2002; Lugo-
Villarino et al., 2003; Xu and Zhang, 2005; Joshi et al., 2007; 
Intlekofer et al., 2008). T-bet is also required for the final 
maturation of NK cells and for the development of invariant 
NKT (iNKT cells; Townsend et al., 2004). T-bet has been 
shown to mediate direct effects on various promoters, to bind 
and modify the effects of other transcription factors, and to fa-
cilitate chromatin remodeling through the regulation of his-
tone methyltransferase activity (Hwang et al., 2005; Mehta 
et al., 2005; Beima et al., 2006; Chen et al., 2006; Djuretic et al., 
2007; Lewis et al., 2007). The key genes regulated by T-bet in 
NK cell development and maturation are not well defined.
In an effort to identify genes involved in NK cell develop-
ment or trafficking, we screened mice carrying ethylnitro-
sourea (ENU)-induced mutations for altered blood NK cell 
numbers  or  surface  phenotypes.  Our  characterization  of  a 
strain with low circulating NK cells led us to identify a role for 
T-bet in promoting S1P5 expression in several cell types and to 
establish a role for S1P5 in NK cell egress from LNs and BM.
RESULTS
Characterization of the ENU strain Duane
Screening peripheral blood for lymphocyte phenotypes re-
sulting  from  ENU-induced  mutations  identified  a  strain, 
Duane, with a low percentage of NK cells in the blood, 
spleen, and liver, but a significantly elevated frequency of   
NK cells in peripheral LNs and BM (Fig. 1 A; and Fig. S1,   
A and B). The blood samples were also screened for CD69, with 
the intent of detecting mutations that altered the ability of 
CD69 to regulate lymphocyte egress (Shiow et al., 2006). An 
increased fraction of Duane NK cells was found to express 
CD69 (Fig. 1 B). Through further flow cytometric analysis of 
various developmental markers, Duane NK cells were found JEM VOL. 206, October 26, 2009 
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splenocytes were cultured for 48 h in conditions condu-
cive to polyclonal T cell activation. Although both Duane 
and wild-type splenocytes activated to the same degree 
(Fig. S2 J), the amount of T-bet protein in Duane cell lysates 
were three- to fourfold lower than those of wild-type mice 
(Fig. S2 K). Interestingly, although some T-bet protein was 
detected in Duane, the NK phenotype of this strain was in-
distinguishable from that of T-bet–null mice (Fig. 1 B), and 
both strains exhibit a severe deficiency in iNKT cells (Fig. S1; 
Townsend et al., 2004).
T-bet function in Duane
To determine if the Duane mutation affected the function of 
T-bet, cells were transfected with an empty vector or a vec-
tor encoding wild-type or Duane T-bet, and the transcrip-
tion of various gene targets was assayed. Overexpression of 
wild-type T-bet resulted in greater than fivefold induction in 
the transcription of IFN-, CCL3, and CXCR3 (Fig. S3 A). 
In contrast, overexpression of Duane T-bet did not result in 
the increased transcription of any of these known T-bet tar-
get genes, suggesting that the Duane mutation has rendered 
encoding T-bet, Tbx21, identified a point mutation resulting 
in the replacement of a single nucleotide in the second intron 
(Fig. S2, C and D). This mutation disrupts an intronic splice 
acceptor site, thereby preventing the normal splicing of the 
T-bet mRNA (Fig. S2, E and F). PCR amplification and se-
quencing of T-bet mRNA isolated from Duane splenocytes 
revealed the use of a cryptic intronic splice acceptor site lo-
cated 24 nucleotides into exon 3 (Fig. S2, F and G). This re-
sults in a predicted, in-frame, eight–amino acid deletion in 
the deduced protein sequence of Duane T-bet (Fig. S2 G). 
Comparison of the predicted protein structure of Duane 
T-bet to the known structure of the T-box domain of Xenopus 
laevis T protein and the predicted structures of other mam-
malian T-box proteins indicates that this deletion corresponds 
to a region adjacent to and including one of the residues in-
volved in known protein–protein interactions (Fig. S2 H).
Expression of T-bet in Duane
PCR analysis of T-bet mRNA levels using primers spanning 
exons 1 and 2 indicated little difference between Duane and 
wild-type NK cells (Fig. S2 I). To assay T-bet protein levels, 
Figure 1.  Identification of the ENU mutant Duane. (A) NK cell frequencies within the indicated tissues of Duane and wild-type B6 mice. Bars represent 
mean values, and circles represent individual animals. Data are representative of at least two Duane and two wild-type mice in each of three independent 
experiments. (B) Representative flow cytometric analysis of NK cells from Duane, Tbx21/, and wild-type B6 mice for cell-surface markers. Plots are represen-
tative of at least three independent experiments, each analyzing at least two Duane and two wild-type mice. PLN, peripheral LN. *, P < 0.005; **, P < 0.0001.2472 T-BET PROMOTES S1P5-DEPENDENT NK CELL EGRESS | Jenne et al.
T-bet regulation of S1P5
In an effort to understand the mechanism behind the NK cell 
accumulation in Duane LNs, we analyzed the expression of 
S1P receptors in NK cells. NK cells were notable in their 
abundant expression of S1P5 (Fig. 3 A; Barrett et al., 2007), 
as reported previously (Walzer et al., 2007b), but they also 
expressed S1P1 (Fig. 3 A). A comparison of Duane and wild-
type NK cells revealed markedly reduced amounts of S1P5 in 
Duane NK cells but comparable amounts of S1P1 between 
the two groups (Fig. 3 B).
To explore the possibility that T-bet was a regulator of 
S1P5 expression, T-bet was overexpressed in WEHI-231 
cells and in primary CD4+ and CD8+ T cells (Fig. 3 C). In 
each case, transduction of cells with a vector containing 
T-bet was sufficient to induce S1P5 expression. Although only 
low levels of S1P5 expression were achieved in WEHI-231 
cells, the magnitude of this induction was similar to that of 
the known T-bet target IFN- (Fig. 3 C). To determine if 
T-bet acted directly on the S1pr5 locus, binding to con-
served 5 and 3 regions of the gene was examined. T-bet 
chromatin immunoprecipitation (ChIP) using lysates from 
cell types known to abundantly express T-bet (Th1 cells and 
effector CD8+ T cells) demonstrated an interaction of T-bet 
with a 3 site (Fig. 3 D).
We addressed whether other cell types that express T-bet 
show S1P5 expression. iNKT cells were found to have high 
S1P5 expression (Fig. 3 E). The failure of iNKT cells to de-
velop in the absence of T-bet prevented us from further test-
ing the connection between T-bet and S1P5 expression in 
these cells. Sorted CD44hi CD4+ and CD8+ T cells, represent-
ing memory and/or effector T cell populations, freshly iso-
lated  from  adult  mice  showed  low  but  measurable  S1P5 
expression as well as T-bet, and the S1P5 transcripts were re-
duced by >50-fold in cells sorted from T-bet–deficient mice 
(Fig. 3 E). Finally, when CD8+ T cells were stimulated with 
antigen under culture conditions that promote development 
of  T-bet–expressing  effector  cells  (Intlekofer  et  al.,  2008), 
there was marked up-regulation of S1P5 and this was depen-
dent on intrinsic T-bet expression (Fig. 3 F). Thus, T-bet 
promotes the expression of the egress receptor S1P5 in NK 
cells and CD8+ effector T cells, and likely also in iNKT cells.
S1P and S1P receptor requirement for NK cell egress  
from LNs
In initial experiments to elucidate the contribution of S1P 
receptors to NK cell egress from secondary lymphoid tissues, 
mice were treated for 20 h with FTY720, and analyzed for 
NK cell and T and B cell numbers in lymph. As previously 
reported, FTY720 treatment resulted in a near complete ab-
sence of T or B cells from the lymph (Fig. 4 A; Mandala et al., 
2002; Matloubian et al., 2004). NK cells, however, were 
present in the lymph but were reduced in number as com-
pared with saline-treated animals (Fig. 4 A). When mice were 
treated with integrin and selectin blocking antibodies to pre-
vent NK cell and lymphocyte entry into lymph nodes, addi-
tional treatment with FTY720 prevented the egress-mediated 
T-bet nonfunctional. Additionally, cotransfection of cells 
with a vector containing Duane T-bet and a luciferase re-
porter coupled to the mouse IFN- promoter region failed 
to result in an increase in luciferase activity, whereas transfec-
tion of a wild-type T-bet vector together with the reporter 
construct resulted in robust luciferase activity (Fig. S3 B).
To further test if any T-bet function remained in Duane, 
we analyzed both T and B cell differentiation in assays previ-
ously demonstrated to be T-bet dependent. Mixed cultures 
of wild-type and Duane T cells under Th1-inducing condi-
tions failed to result in the expression of IFN- within the 
Duane cells despite robust expression in the co-cultured 
wild-type cells (Fig. S3 C). This result was similar to that ob-
served  in  a  wild-type  and  T-bet–deficient  cell  co-culture 
(Fig. S3 C). Likewise, co-culture of wild-type and Duane B 
cells under IgG2a-inducing conditions resulted in expression 
of IgG2a by the CD45.1+ wild-type cells but not the Duane 
B cells (Fig. S3 D). From these assays, the Duane mutation 
appears to result in a functionally null T-bet phenotype.
Figure 2.  Peripheral lymph node NK cell accumulation in Duane 
results from a cell-intrinsic egress defect. (A) Analysis of wild-type 
mice reconstituted with a mix of wild-type and Duane BM. Some mice 
(PLN+Block) received integrin and selectin blocking antibodies 40 h before 
analysis. Values are reported as a ratio of Duane (CD45.2) to wild-type 
(CD45.1) cells. At least two untreated and two treated chimeras were 
analyzed in each of two independent experiments. (B) Analysis of wild-
type B6 mice 24 h after adoptive transfer of either Duane or wild-type 
splenocytes. Values are reported as a ratio of transferred NK cells recov-
ered from the spleen (as a percentage of transferred B cells) to transferred 
NK cells in the peripheral LNs (as a percentage of transferred B cells). Data 
were obtained from two independent experiments, each composed of two 
recipients receiving Duane splenocytes and two recipients receiving wild-
type splenocytes. Bars represent mean values, and circles represent indi-
vidual animals. PLN, peripheral lymph node. *, P < 0.005; **, P < 0.001.JEM VOL. 206, October 26, 2009 
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Figure 3.  Reduced S1P5 but not S1P1 expression in Duane cells and T-bet–mediated induction of S1P5 expression. (A–C) Quantitative PCR 
analysis of S1PR or IFN- transcript expression in (A) total splenocytes and sorted splenic NK cells from a wild-type mouse, (B) wild-type and Duane 
splenic NK cells (bars represent mean values, and circles represent sorted NK samples from individual animals), and (C) either vector- or T-bet–trans-
duced WEHI-231 cells (left; bars represent mean values, and circles represent individual transductions) or primary T cells (right; bars represent indi-
vidual transductions). (D) T-bet associates with the region 3 of the S1pr5 gene. Primary CD4+ T cells were isolated from either Tbx21/ (lanes 1–3) or 
wild-type (lanes 4–6) mice, and were polarized in Th1 conditions for 6 d (results are representative of two independent experiments, each using cells 
pooled from two individual animals). CD8+ T cells were isolated from mice infected with LCMV (lanes 7–9; results are representative of two independent 
immunoprecipitations using cells pooled from three individual animals). A standard ChIP analysis was then performed with a T-bet–specific antibody 
(lanes 1, 4, and 7) or an IgG control (lanes 3, 6, and 9). A standardized aliquot of the input chromatin was also examined as a control. Gene-specific 
primers were used to amplify the ChIP samples, as indicated to the left of the gel images. (E and F) Quantitative PCR analysis of T-bet or S1P5 transcript 
expression in (E) various lymphocyte subsets sorted from naive wild-type or T-bet–deficient mice (bars represent mean values, and circles represent 
sorted cell samples from individual animals; data were obtained from three independent experiments), and (F) in vitro–generated, sorted, polyclonal-
activated (CD44hi) or LCMV antigen–specific (GP33+) CD8+ effector T cells (bars represent samples sorted from cells pooled from at least three individual 
animals). , PCR signal < 0.001; , PCR signal below detection threshold.2474 T-BET PROMOTES S1P5-DEPENDENT NK CELL EGRESS | Jenne et al.
decay of T cell numbers, but NK cell numbers continued to 
decline (Fig. S4 A), indicating the presence of an FTY720-
insensitive egress mechanism. Thus, FTY720 treatment ap-
pears to reduce but not block NK cell egress from LNs into 
lymph. To determine the impact of FTY720 exposure on 
S1P receptor expression, we examined the surface abundance 
of FLAG-tagged S1P1 and S1P5 in transduced WEHI-231 B 
lymphoma cells in the presence of either S1P or FTY720-P. 
As  previously  reported  (Gonzalez-Cabrera  et  al.,  2007; 
Oo et al., 2007), exposure to either S1P or FTY720-P, even 
in small quantities, was sufficient to induce loss of cell-surface 
S1P1. Neither compound was able to affect the surface ex-
pression of S1P5 (Fig. S4 B). The resistance of S1P5 to down-
modulation is unlikely to be caused by overexpression because 
the surface abundance of the receptor was lower than for 
S1P1 (Fig. S4 B). These observations suggest that S1P5 on 
lymphoid cells may be less sensitive than S1P1 to agonist-
mediated down-modulation.
The effects of FTY720 on T and B cell trafficking have 
been associated with intrinsic S1P1 function in these cells 
(Matloubian et al., 2004). To determine if S1P1 played a role 
in NK cell trafficking, mixed S1P1-deficient and wild-type 
BM chimeras were examined (Fig. 4 B). Compared with 
control mixed chimeras, there was a small but significant ac-
cumulation  of  S1P1-deficient  NK  cells  in  LNs  compared 
with blood and spleen, and lower numbers of S1P1-deficient 
NK cells in lymph (Fig. 4 B). There was also a mild accumu-
lation of S1P1-deficient cells in the BM. Thus, like FTY720 
treatment, hematopoietic S1P1 deficiency reduces but does 
not block NK cell egress from LNs into lymph.
To understand the role of S1P5 in NK cell egress from 
lymphoid tissues, we generated S1P5-deficient mice (Fig. S5). 
The S1P5-deficient founders were backcrossed three times 
to  B6  mice,  and  BM  from  either  these  mice  or  their 
S1P5
+/+ littermates was used to generate mixed BM chime-
ras. These chimeras demonstrated a significant accumula-
tion of S1P5-deficient NK cells in the BM and in the LNs, 
together with a deficit of S1P5-deficient NK cells in the 
blood and the spleen relative to wild-type NK cells (Fig. 4 C), 
Figure 4.  NK cell egress requires S1P, and uses both S1P5 and an 
FTY720-sensitive receptor. (A) Cellular composition of lymph collected 
from wild-type mice treated for 20 h with 1 mg/kg FTY720. Values are 
reported as the number of cells in the lymph of FTY720-treated animals 
as a percentage of lymph cell numbers in saline-treated animals. Data are 
derived from at least three independent experiments. (B) Examination of 
wild-type B6 mice reconstituted with a mix of CD45.1+ wild-type and 
CD45.2+ S1pr1/ or control S1pr1+/+ BM. Values are reported as a ratio 
of S1P1-deficient or control (CD45.2) to wild-type (CD45.1) cells. To ac-
count for differences between independent groups of chimeras, NK cell 
ratios were normalized to BM CD19+ B cell ratios for each mouse. Data 
are derived from at least three independent experiments. (C) Examination 
of wild-type B6 mice reconstituted with a mix of CD45.1+ wild-type and 
CD45.2+ S1pr5/ or CD45.2+ S1pr5+/+ littermate control BM. Some mice 
(Lymph+FTY) received 1 mg/kg FTY720 i.p. 20 h before analysis. Values are 
reported as a ratio of S1P5-deficient or control (CD45.2) to wild-type 
(CD45.1) cells. NK cell ratios were normalized to BM CD19+ B cell ratios 
for each mouse. Data are derived from two independent experiments.  
(D) Analysis of NK cell distribution in Sphk-deficient and littermate con-
trol mice. Values for BM, spleen, and peripheral LNs (six nodes) represent 
absolute NK cell numbers; values for lymph represent cells per microliter 
of lymph. Sphk ∆ represents mice that were Sphk2 null, were deficient for 
one allele of Sphk1, and had the second allele of Sphk1 excised. Control 
represents Sphk2-null mice with at least one functional allele of Sphk1. 
Data are derived from at least three independent experiments. Bars repre-
sent mean values, and circles represent individual animals. n.s., not sig-
nificant; PLN, peripheral LN. *, P ≤ 0.05; **, P < 0.005.
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with S1P1, and cross-linking of FLAG-tagged S1P1 results 
in the induction of CD3 signaling, as evident by the ex-
pression of an NFAT-regulated GFP reporter (Fig. 6 A). 
When FLAG-S1P5 was cross-linked, no expression of GFP 
was detected, indicating a failure of CD69 to associate with 
S1P5. Further, as previously reported (Shiow et al., 2006), 
immunoprecipitation  of  FLAG-S1P1  resulted  in  the  pull 
down  of  hemagglutinin  (HA)-tagged  CD69  (Fig.  6  B). 
Immunoprecipitation of FLAG-S1P5, however, even from 
cells expressing higher amounts of the S1P receptor (S1P5 ++ 
vs. S1P1 +), failed to pull down any detectable HA-CD69 
(Fig. 6 B). In agreement with the lack of interaction between 
CD69 and S1P5, CD69 showed no ability to inhibit S1P5-
dependent S1P chemotaxis in Transwell assays with trans-
duced cells (Fig. 6 C).
These observations suggested that, compared with T cells, 
NK cells may be resistant to LN egress inhibition caused by 
CD69 up-regulation. To assess the ability of CD69 to block 
NK egress in vivo, we analyzed the cellular composition of 
lymph from animals treated with the type I IFN–inducing 
agent poly I:C for 6 h. Treatment of mice with poly I:C has 
been previously demonstrated to efficiently block T cell 
in agreement with previous findings (Walzer et al., 2007b). 
In addition, there was a lower ratio of S1P5-deficient NK 
cells to wild-type NK cells in the lymph as compared with 
the peripheral LNs, indicating a reduced capacity of the 
S1P5-deficient NK cells to egress from LNs into lymph. 
This ratio skewed further in favor of the wild-type NK cells 
if the mice were treated with FTY720 for 20 h before analy-
sis (Fig. 4 C). These results indicate that S1P5 is important 
for the egress of NK cells from LNs, while also indicating 
that some NK cell exit from LNs is S1P5 independent and 
can be attributed to a receptor that is modulated by FTY720, 
most likely S1P1.
To address the role of S1P in NK cell egress, we ana-
lyzed mice deficient in Sphk2 and conditionally ablated for 
Sphk1, and that lacked detectable circulatory S1P (Pappu 
et al., 2007). In these mice, we observed a significant reduc-
tion in the number of NK cells in the spleen but found 
these mice to have a normal or slightly elevated number of 
NK cells in peripheral LNs (Fig. 4 D). These mice also 
demonstrated a significant accumulation of NK cells in the 
BM. Analysis of lymph from these animals revealed a signif-
icant reduction in the number of NK cells, indicating a fail-
ure to egress from the peripheral lymphoid tissues in the 
absence of S1P (Fig. 4 D).
Reduced NK cell numbers in BM sinusoids  
of S1P-deficient mice
Cellular egress from the BM occurs via BM sinusoids. Re-
cent work has shown that a 2-min in vivo exposure to PE-
coupled anti-CD45 antibody selectively labels sinusoidal cells 
among BM cells (Pereira et al., 2009). Using this labeling 
procedure, we found that 14% of BM NK cells were situ-
ated inside sinusoids (Fig. 5 A). In S1P-deficient mice, this 
frequency fell to <6% (Fig. 5 A). Previous studies have shown 
a tight relationship between S1P1 surface abundance on T cells 
and local S1P concentrations (Lo et al., 2005; Schwab et al., 
2005; Pappu et al., 2007). Analysis of T cells in the BM 
showed that S1P1 was present in higher amounts on paren-
chymal compared with sinusoidal cells (Fig. 5 B), suggesting 
the existence of an increasing S1P gradient between paren-
chyma and sinusoid. These observations, coupled with the 
lower total NK cell numbers in the periphery, suggest that 
the ability of NK cells to exit from BM parenchyma to sinu-
soid is diminished in the absence of S1P.
S1P5 mediates the egress of activated NK cells
CD69 is rapidly expressed at high levels on activated NK 
cells and may have a role in NK cell–mediated cytotoxicity 
(Karlhofer  and  Yokoyama,  1991).  CD69  has  also  been 
shown to bind and inhibit the function of S1P1 in T cell 
egress (Shiow et al., 2006). To test whether CD69 inter-
acts with S1P5, we used a coexpression system whereby a 
FLAG-tagged S1P receptor was coexpressed with a fusion 
molecule consisting of the extracellular and transmembrane 
domains of CD69 coupled to the intracellular domain of 
CD3  (Fig.  S6).  CD69  is  known  to  physically  associate 
Figure 5.  Reduced numbers of NK cells in BM sinusoids of S1P-
deficient mice and S1P1 surface expression on BM T cells. (A, left) 
NK cells present in the BM sinusoids of Sphk-deficient and littermate 
control mice were labeled in vivo by a 2-min i.v. treatment with PE-con-
jugated anti-CD45.2. Numbers indicate the frequency of PE+ (sinusoidal) 
cells among total NK cells. (right) Summary of data for three mice. Data 
are representative of two independent experiments, each involving at 
least two Sphk-deficient and two littermate control mice. Bars represent 
mean values, and circles represent individual animals. (B, left) Control 
mice were treated i.v. with PE-conjugated anti-CD45.2 for 2 min. Cells 
were gated on CD4+, TCR+, NK1.1 cells and resolved for sinusoidal 
labeling. (right) Comparison of S1P1 surface expression levels between 
PE (parenchymal) and PE+ (sinusoidal) CD4+ T cells. Data are representa-
tive of two experiments, each analyzing two animals. *, P < 0.05.2476 T-BET PROMOTES S1P5-DEPENDENT NK CELL EGRESS | Jenne et al.
metric analysis confirmed that all NK cells in the lymph 
appeared activated and expressed high amounts of CD69 
(Fig. 6 E), indicating that S1P5 is able to mediate egress of 
activated NK cells even in the presence of CD69.
egress from peripheral LNs (Shiow et al., 2006). Although 
nearly all T cell egress into lymph was inhibited by poly I:C 
treatment, a significant percentage of NK cells was found to 
retain the ability to enter the lymph (Fig. 6 D). Flow cyto-
Figure 6.  CD69 neither associates with nor inhibits S1P5 function. (A) NFAT-GFP reporter expression in 2B4 cells transduced with the indicated 
constructs and treated with anti-CD69 antibody (top) or anti-FLAG antibody (bottom). Numbers indicate percentages of cells expressing the reporter. Data 
are representative of six independent experiments. (B) Western blot analysis of total lysates or anti-FLAG immunoprecipitates from WEHI-231 cells trans-
duced with the indicated transgenes and sorted for CD69 and FLAG expression (+, low; ++, high). WB indicates the antibody used for Western blotting, 
and IP indicates the antibody used for immunoprecipitation. Data are representative of two independent experiments. (C) Transwell migration assay of 
untransduced WEHI-231 cells (control) or cells expressing S1PR transgenes alone or together with a CD69 transgene. Values are reported as the percent-
age of input cells migrating to the lower chamber during the 3-h assay. Columns represent the means of duplicate wells, and the bars represent the range 
within a single experiment. Data are representative of three independent experiments. (D) Cellular composition of lymph from animals treated with poly I:
C for 6 h before analysis. Values are reported as the number of cells in the lymph of poly I:C–treated animals as the percentage of cells in the lymph of 
the PBS-treated animals. Data are representative of at least three independent experiments. Bars represent mean values, and circles represent individual 
animals. (E) Representative flow cytometric analysis of lymph and LN NK cells from saline- or poly I:C–treated mice. Data are representative of at least 
three independent experiments. PLN, peripheral LN. **, P < 0.005.JEM VOL. 206, October 26, 2009 
ARTICLE
2477
is consistent with studies showing minimal changes in blood 
NK cell numbers in FTY720-treated humans (Vaessen et al., 
2006) and mice (Walzer et al., 2007b). The ability of many 
NK cells to egress from LNs after FTY720 treatment pro-
vides further evidence against models arguing that FTY720 
inhibits egress by acting on endothelial or stromal S1P recep-
tors to close LN egress portals (Rosen and Goetzl, 2005). 
iNKT cell recirculation is also relatively resistant to FTY720 
treatment (Allende et al., 2008). Our finding of S1P5 expres-
sion in these T-bet–dependent cells provides a possible ex-
planation for this finding, and it will be important in future 
studies to track the impact of S1P5 deficiency on iNKT cell 
as well as NK cell and effector CD8+ T cell function.
Although S1P5 appears to be the dominant S1P receptor in 
NK cells, we did observe S1P1 expression in these cells, and 
S1P1 deficiency caused a measurable decrease in NK cell repre-
sentation in lymph. Although a previous study suggested S1P1 
may not be present in NK cells (Walzer et al., 2007b), S1P1 
transcripts were within 10-fold of the amounts present in 
T and B cells in that study, as observed in the present work. 
The greater effect of S1P deficiency than S1P5 deficiency on 
NK cell numbers in lymph also supports the view that S1P1 
plays a role in these cells, as does the finding that FTY720 treat-
ment is able to further reduce the egress of S1P5-deficient NK 
cells. It remains to be determined whether these receptors are 
coexpressed in all NK cells or expressed in separate subsets.
Within the spleen, NK cells are largely excluded from 
the white pulp and are localized in the red pulp (Walzer et al., 
2007a).  S1P1  deficiency  or  FTY720  treatment  depletes   
T and B cells from red pulp while leaving cells within the 
white pulp. This likely reflects a role for S1P and S1P1 in 
overcoming  chemokine-mediated  retention  in  the  white 
pulp (Pham et al., 2008). The general NK cell deficiency in 
the spleen of T-bet–, S1P5-, and S1P-deficient mice is con-
sistent with observations that few splenic NK cells are pres-
ent within the white pulp, and with evidence that positioning 
in the red pulp is Gi independent and, thus, most likely not 
chemokine mediated (Grégoire et al., 2007). The lack of   
a Gi mediated retention mechanism may well obviate the 
need for S1P receptor signaling during splenic egress (Pham 
et al., 2008). We suspect that in the absence of S1P5 or S1P, 
NK cells become trapped in LNs and BM at the expense of 
representation in blood and the splenic red pulp. We note 
that the reduction in NK cell numbers in the spleens and 
livers of T-bet–deficient mice exceeds their numerical accu-
mulation in LNs and BM, likely reflecting a requirement for 
T-bet in the maturation or maintenance of NK cells. Al-
though T-bet has a large number of target genes, there may 
be a similar deficiency in the total peripheral NK cell pool in 
S1P5-deficient mice (Walzer et al., 2007b), raising the possi-
bility that T-bet–driven S1P5 expression is required for nor-
mal NK cell maturation or homeostasis, a topic that will 
need further assessment in future studies.
The requirements for cell egress from the BM are poorly 
understood. CXCR4 has an established role in mediating 
precursor retention in the BM and there is evidence that 
DISCUSSION
T-bet has been previously demonstrated to be important for 
normal NK cell development and survival (Townsend et al., 
2004). NK cells from T-bet–deficient mice appear pheno-
typically immature and hyperactivated, and undergo increased 
rates of cell death. Although these observations may partly 
explain the observed deficit of NK cells in some peripheral 
sites of T-bet–deficient mice (blood, spleen, and liver), they 
do not explain the observed increase in NK cell number 
within the BM and peripheral LNs. Our findings indicate 
that S1P5 is likely the key gene acting downstream of T-bet 
to allow the normal LN and BM egress of NK cells, and thus, 
recirculation to other sites. T-bet also promotes expression of 
CXCR3, a receptor involved in NK cell entry to inflamed 
LNs (Martín-Fontecha et al., 2004), indicating that part of 
the T-bet–induced gene expression program acts to coordi-
nate NK cell trafficking. ChIP analysis identified the ability 
of T-bet to bind a conserved element 3 of the S1pr5 gene. 
This finding, together with our observation of T-bet–induced 
expression of S1P5 in three different transduced cell types, as 
well as the T-bet dependence of S1P5 expression in NK and 
CD8+ T cells, establishes that S1P5 is a common component 
of the T-bet gene expression program.
Within a day after activation in peripheral LNs, “primed” 
NK cells can be detected at distal sites such as the spleen, 
lungs, and liver (Lucas et al., 2007). This apparent ability of 
acutely activated NK cells to traffic from LNs seemed con-
trary to what has been observed for activated T cells, where 
CD69 inhibits S1P1-mediated egress (Shiow et al., 2006). 
Our findings suggest that this is likely a consequence of S1P5 
being resistant to CD69-mediated inhibition. The expression 
of S1P5 by effector CD8+ T cells suggests that these cells may 
also be competent to egress while in an activated state. Simi-
lar trafficking patterns of NK cells and effector CD8+ T cells 
have been noted (Grégoire et al., 2007). In this regard, it is 
notable that CD69 is a member of the NK receptor C-type 
lectin–like family, and some studies have suggested that it has 
an effector role (Karlhofer and Yokoyama, 1991), although 
no extrinsic ligand has yet been identified. By facilitating 
egress of CD69+ cells, S1P5 may allow this CD69 effector 
function to occur. Many iNKT cells express CD69 (Matsuda 
et al., 2000), and we propose that T-bet–induced S1P5 also 
functions to facilitate egress and recirculation of these cells.
FTY720, in the active phosphorylated form, is a receptor 
agonist  that  is  also  a  functional  antagonist  of  S1P1,  and 
FTY720 treatment causes rapid down-modulation of S1P1 
on T cells, an effect that has correlated tightly with FTY720-
mediated inhibition of T cell egress (Matloubian et al., 2004; 
Pham et al., 2008). In vitro studies have shown that FTY720-P 
causes internalization, ubiquitination, and degradation of 
S1P1 (Gonzalez-Cabrera et al., 2007; Oo et al., 2007). In our 
studies, we found that in contrast to S1P1, S1P5 was resistant 
to FTY720-induced down-modulation, and our data suggest 
that  this  receptor  continues  to  support  NK  cell  egress  in 
FTY720-treated hosts. The finding that NK cell egress is rela-
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later. For in vivo lymphocyte activation, mice received 100 µg of poly I:C 
(GE Healthcare) in PBS i.v. 6 h before analysis. Lymph collection and in 
vivo labeling of BM sinusoidal contents have been previously described 
(Matloubian et al., 2004; Pereira et al., 2009). For isolation of liver NK cells, 
livers were harvested and rinsed in PBS. The liver was disrupted by forcing 
through a 70-µm nylon mesh, and cells were washed in PBS, resuspended in 
44% Percoll (GE Healthcare) and layered on 56% Percoll. Preparations were 
spun for 20 min at 2,000 rpm in a bench-top centrifuge with no brake, after 
which the interface containing the lymphocytes was collected and washed in 
PBS. Lymphocytic choriomeningitis (LCMV) infections were performed as 
previously described (Intlekofer et al., 2008), and CD44hi CD8+ T cells were 
sorted on day 8 after infection from total splenocytes.
S1pr5 targeting vector construction, embryonic stem (ES) cell ma-
nipulation, and generation of mutant mice. A mouse genomic library 
was screened with an S1P5 mouse cDNA, and an S1pr5-containing ge-
nomic clone with sufficient flanking sequence on both sides of the S1P5 
coding region was identified. The S1pr5 targeting construct in pBluescript 
(Agilent Technologies) has an 2.6-kb short arm and an 3.2-kb long 
arm, and a portion of the S1P5 coding region was fused with DsRed from 
DSRed-N1 (Takara Bio Inc.). Except for the first seven amino acids, the 
entire S1P5 coding region was deleted. The orientation of the neomycin 
cassette under the control of the phosphogylcerate kinase promoter is op-
posite to that of the S1pr5 genomic locus. All cloning was performed using 
standard molecular biology techniques.
E14Tg2a stem cells were electroporated with 25 µg of Sal I–linearized 
targeting vector at the Scripps Research Institute Mouse Genetics Core, and 
150 colonies were isolated. Genomic DNA was prepared from isolated 
stem cells digested with BamHI and Southern blotted with a random-primed 
32P-labeled external probe. Two independent ES cell clones with recom-
bined S1pr5 loci were identified and injected into blastocysts. One line of 
chimeric mice derived from the identified ES cell clones transmitted the 
mutant allele to the germline. The resultant heterozygous mice were crossed, 
and the presence of wild-type, heterozygous, and null mutants was con-
firmed by Southern blotting of BamHI-digested tail DNA with the external 
probe, and PCR using S1P5- and DsRed-specific primers (Table S1). PCR 
was performed under standard conditions, except for the addition of 10% 
DMSO (final) to reaction mixes.
Genetic mapping of the Duane mutation. Affected Duane mice were 
crossed onto either the C57BL/10 or the CBA/J background to generate het-
erozygous F1 mice. These F1 mice were either intercrossed (C57BL/10 map-
ping) or backcrossed to an affected Duane mouse (CBA/J mapping) to yield 
mice homozygous for the Duane mutation and carrying a mix of C57BL/6 
and background C57BL/10 or CBA/J SNPs. Genomic DNA was isolated 
from both affected and unaffected mice from the C57BL10/mapping cross 
and was used as template material for SNP mapping using an Amplifluor assay 
(Millipore) with Platinum Taq (Invitrogen). SNP markers were spaced ap-
proximately every 20 Mbp throughout the genome. To confirm the linkage 
and to further narrow the interval, genomic DNA from both affected and un-
affected mice from the CBA/J mapping cross was isolated and used as a tem-
plate material for SNP typing in the suspected interval. Once a defined interval 
was established, the T-bet–encoding gene was sequenced from genomic DNA 
from both affected Duane and wild-type mice. All exons were amplified by 
PCR with primers (Table S1) spanning the whole exon and the flanking in-
tronic regions. To confirm the transcript sequence, RNA was isolated with 
TRIzol reagent (Invitrogen) from mutant, heterozygous, and wild-type mice, 
and cDNA was synthesized with the SuperScript II reverse transcription kit 
(Invitrogen). The Duane deletion was confirmed with primers located in ex-
ons 2 and 4 (Table S1). All PCR products were amplified by using AccuPrime 
High Fidelity Taq (Invitrogen), gel purified, and sequenced on a sequencer 
(ABI 3730; Applied Biosytems) at the ACRF Biomolecular Resource Facility 
(JCSMR, ANU) according to the manufacturer’s protocol.
Protein  modeling. T-bet protein models were generated by using the 
Geno3D server (available at http://geno3d-pbil.ibcp.fr; Combet et al., 2002). 
NK cells are retained by CXCR4, and down-regulation of this 
receptor coincides with maturation and exit from the BM 
(Beider et al., 2003; Bernardini et al., 2008). However, ma-
ture NK cells retain substantial amounts of CXCR4 and 
are highly responsive to CXCL12 (Bernardini et al., 2008). 
We  suggest  that  the  requirement  for  S1P  for  efficient 
egress of NK cells from BM parenchyma into sinusoids re-
flects a role for S1P, together with S1P5 and S1P1, in over-
coming CXCR4–CXCL12–mediated retention, analogously 
to S1P–S1P1 overcoming the CCR7–CCL21–mediated re-
tention of T cells in lymph nodes (Pham et al., 2008). These 
findings point to the possibility that S1P and S1P receptors 
function in the BM egress of additional cell types. This has 
important implications for the application of therapies that 
interrupt S1P receptor function.
In summary, our findings establish that T-bet promotes 
S1P5 expression and that S1P5, and its ligand S1P, are re-
quired for NK cell egress from LNs and BM. T-bet–depen-
dent S1P5 expression also occurs in effector CD8+ T cells. 
These findings extend the paradigm that S1P promotes egress 
through actions on migrating S1P1
+ cells by showing that a 
second leukocyte S1P receptor is involved in egress. We pro-
pose that the differential use of S1P5 by NK and effector 
CD8+ T cells facilitates their egress in a CD69+ effector state. 
Finally,  our  study  adds  to  recent  findings  (Walzer  et  al., 
2007b) to suggest strongly that S1P and S1P receptors are re-
quired for efficient NK cell egress from the BM.
MATERIALS AND METHODS
Mice, ENU mutagenesis, chimeras, lymphocyte transfers, and treat-
ments. C57BL/6 (B6) and CD45.1-congenic B6 mice were obtained from 
the National Cancer Institute (NCI). C57BL/10 and CBA/J mice were ob-
tained from the Australian Phenomics Facility, Australian National University 
(ANU). Tbx21/ mice were obtained from the Jackson Laboratory. All ex-
periments conformed to ethical principles and guidelines approved by the 
University of California, San Francisco Institutional Animal Care and Use 
Committee, the ANU Animal Experimentation Ethics Committee, and the 
Scripps Research Institute Animal Research Committee. The generation of 
S1P5-deficient mice is described in detail in the following section. S1P5-defi-
cient mice were crossed three times to B6 mice. The generation of S1P1-
deficient mice, S1P1-deficient fetal liver chimeras, and Sphk-deficient mice 
have been previously described (Liu et al., 2000; Matloubian et al., 2004; 
Pappu et al., 2007). S1P1+/ mice were provided by R. Proia (National In-
stitute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD), and 
Sphk1f/ Sphk2/ mice were provided by S. Coughlin (University of Cali-
fornia, San Francisco, San Francisco, CA). The Duane strain was established 
through ENU-mediated mutagenesis of B6 mice, as previously described 
(Nelms and Goodnow, 2001; Shiow et al., 2008). Mapping and sequencing 
of the Duane mutation was performed at the Australian Cancer Research 
Foundation (ACRF) Biomolecular Resource Facility (John Curtin School of 
Medical Research [JCSMR], ANU) and is described in Genetic mapping of 
the Duane mutation. Once identified, the Duane strain was backcrossed onto 
B6 mice for three additional generations. BM chimeras were generated by i.v. 
transferring 3–6 × 106 BM cells into lethally irradiated (2 × 550 rads) B6-
CD45.1 recipients.
For short-term adoptive transfers of splenocytes, 2.5–3.5 × 107 donor 
cells were transferred i.v. into each B6-CD45.1 recipient. Integrin and 
L-selectin blockade was mediated by the administration of 100 µg each of anti–
L integrin (clone M17/4), anti–4 integrin (clone PS/2), and anti–L-selectin 
(clone MEL14) antibodies in PBS i.v. 40 h before analysis. FTY720-treated 
animals received 1 mg/kg of the drug injected i.p. and were analyzed 20–24 h JEM VOL. 206, October 26, 2009 
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Immunoprecipitation and Western blotting. Immunoprecipitation was 
performed as previously described (Shiow et al., 2006). For immunoblot 
analysis, cell pellets were lysed in 0.875% Brij97, 0.125% NP-40, 150 mM 
NaCl, 10 mM Tris-HCl (pH 7.4), and 0.02% NaN3 buffer containing pro-
tease inhibitors (Sigma-Aldrich). Samples were resolved by 10% SDS-PAGE 
(NuPAGE; Invitrogen) and transferred to Immobilon-FL membranes (Mil-
lipore). Membranes were blocked with buffer (LI-COR Biosciences) and 
stained with anti–T-bet (clone 39D raised against full-length mouse T-bet; 
Santa Cruz Biotechnology, Inc.), rabbit anti-actin (Sigma-Aldrich), anti-
FLAG (clone M1; Sigma-Aldrich), and biotin-conjugated anti-HA (clone 
3F10; Roche). Products were detected with IRDye 680–conjugated goat 
anti–mouse Ig, IRDye 800CW–conjugated streptavidin (LI-COR Biosci-
ences), or IRDye 700DX–conjugated donkey anti–rabbit Ig (Rockland), 
and imaged on an infrared imager (Odyssey; LI-COR Biosciences).
ChIP.  ChIP  was  performed  as  previously  described  (Miller  et  al., 
2008). Primers specific to the 3 region of the S1pr5 gene were as fol-
lows:  forward,  5-CACCTTGCAGTAGCTCTGAG-3,  and  reverse, 
5-GGAGCCAGCCGGACTGTATC-3.
Luciferase reporter and endogenous T-bet target transcription anal-
yses. Luciferase and endogenous gene quantitative RT-PCR analyses were 
performed as previously described (Miller et al., 2008).
NFAT-GFP reporter assay. S1P receptor and CD69–hCD3 fusion pro-
teins were cotransduced into mouse 2B4 hybridoma cells with an NFAT-GFP 
reporter construct and were assayed as previously described (Arase et al., 
2002; Rosen et al., 2005; Shiow et al., 2006).
S1PR down-modulation assay. WEHI-231 cells stably expressing FLAG-
tagged S1PR were washed twice in RPMI 1640 medium with 10 mM 
Hepes and 0.5% fatty acid–free BSA (EMD; BSA-RPMI), and then incu-
bated in BSA-RPMI for 30 min at 37°C. S1PR ligands indicated in the 
figures (S1P or FTY720-P) were titrated into BSA-RPMI in a 96-well 
U-bottom plate. Cells were added to each well, and the plate was incubated 
for 40 min at 37°C. The resulting surface S1PR levels were measured by 
flow cytometry using the anti-FLAG antibody (clone M2; Sigma-Aldrich).
Transwell  migration. Transwell migrations were performed as previ-
ously described (Matloubian et al., 2004; Lo et al., 2005). In brief, trans-
duced WEHI-231 cells were harvested, washed, and incubated for 30 min 
at 37°C in migration media (RPMI 1640 supplemented with 10 mM 
Hepes, 100 U/ml penicillin–streptomycin, and 0.5% fatty acid–free BSA). 
106 cells were loaded into 5-µm Transwells (Sigma-Aldrich) and allowed to 
transmigrate for 3 h in response to media alone, stromal cell–derived factor 
1 (PeproTech), or S1P (Sigma-Aldrich). Contents from the bottom of each 
well were harvested and enumerated by flow cytometry.
Online supplemental material. Table S1 lists nucleotide sequences for 
PCR primer and probe sets. Fig. S1 contains representative flow cytometric 
analysis and NK cell counts from various tissues from Duane and wild-type 
mice. Fig. S2 presents mapping and nucleotide sequencing of the causative 
genetic lesion within the Duane Tbx21 gene, amplification and sequencing 
of Duane and wild-type T-bet cDNA, and quantitative PCR and West-
ern blot analysis of T-bet expression in Duane and wild-type mice. Fig. S3 
presents assays demonstrating that the Duane T-bet mutation results in a 
functionally null phenotype. Fig. S4 contains analysis of NK cell numbers 
in peripheral LNs from mice after blocking lymphocyte entry in the pres-
ence or absence of FTY720, and representative flow cytometric analysis of 
untreated and S1P- or FTY720-treated 2B4 hybridoma cells transduced 
with either FLAG-S1P1 or FLAG-S1P5. Fig. S5 illustrates the generation of 
S1P5-deficient mice. Fig. S6 presents representative cell-surface staining for 
CD69 and FLAG on transduced 2B4 hybridoma cells used for NFAT-GFP 
reporter assays. Online supplemental material is available at http://www 
.jem.org/cgi/content/full/jem.20090525/DC1.
Resulting models were visualized and colored using the DeepView: Swiss-
PdbViewer software package (available at http://www.expasy.org/spdbv/; 
Guex and Peitsch, 1997). Final images were rendered with the Persistence of 
Vision Raytracer (POV-Ray, version 3.6.1a; Hallam Oaks Pty. Ltd.).
Cell-culture conditions. For polyclonal T cell stimulation, splenocytes 
were first depleted of B220+, NK1.1+, CD11b+, CD11c+, and Gr1+ cells 
by using a cell separator (autoMACS; Miltenyi Biotec). The remaining   
T cells were resuspended in RPMI Complete (RPMI 1640 [Cellgro] supple-
mented with 10% FBS [Invitrogen], 10 mM Hepes [Cellgro], 100 U/ml 
penicillin–streptomycin [Thermo Fisher Scientific], and 50 µM 2-mercap-
toethanol) and were plated at 2.5 × 106 cells/ml in 24-well plates precoated 
with 3 µg/ml anti-CD3 (clone 2C11) and 0.5 µg/ml anti-CD28 (clone 
37.51). After 48 h of culture, cells were harvested for flow cytometric and 
immunoblotting analysis.
Isotype class switch assays were performed with total splenocytes. Cells 
were resuspended in RPMI Complete supplemented with 5 µg/ml F(ab)2 
goat anti–mouse IgM (Jackson ImmunoResearch Laboratories), 100 µg/ml 
IFN- (R&D Systems), and 20 µg/ml LPS (Sigma) and were plated at 2.5 × 
105 cells/ml in 24-well plates. Fresh media was added to the cultures after 
48 h, and cells were harvested for flow cytometric analysis after 96 h.
For Th1 cell differentiation assays, total splenocytes were cultured in 
T cell media (Iscove’s medium [Cellgro] with 10% FBS, 1 mM sodium 
pyruvate, 100 U/ml penicillin–streptomycin, 2.5 µM 2-mercaptoethanol, 
and 20 U/ml human IL-2 [NCI Preclinical Repository]) supplemented 
with  20  ng/ml  of  mouse  IL-12  (R&D  Systems),  10  µg/ml  anti–IL-4 
(clone 11B.11), 0.5 µg/ml anti-CD3 (clone 2C11), and 2 µg/ml anti-
CD28 (clone 37.51). Cells were resuspended at 3 × 106 cells/ml and cul-
tured in 24-well plates. After 72 h, cultures were transferred into 6-well 
plates and supplemented with fresh T cell media supplemented with IL-2, 
IL-12, and anti–IL-4, and then cultured for an additional 48 h. Before 
flow  cytometric  analysis,  cells  were  stimulated  with  100  ng/ml  PMA 
(Sigma-Aldrich) and 2 µg/ml ionomycin (EMD) for 3 h in the presence 
of GolgiPlug (BD). CD8+ effector T cells were generated by A. Intlekofer 
(University of Pennsylvania, Philadelphia, PA), as previously described 
(Intlekofer et al., 2005).
Quantitative PCR. For quantitative PCR, total RNA was isolated from 
frozen cell pellets with the RNeasy Micro Kit (QIAGEN) or from freshly 
dissected spinal cords with TRIzol reagent. cDNA was synthesized from 
cell pellets by using Moloney murine leukemia virus (Invitrogen) or from 
DNase-treated spinal cord RNA by using SuperScript II reverse transcrip-
tion, and served as a template for subsequent amplifications using either 2× 
SYBR Green (Roche) or AmpliTaqGold (Applied Biosystems) PCR kits. 
Samples were analyzed using an ABI 7300 (Applied Biosystems).
Retroviral vector constructs and transductions. Construction of an 
MSCV2.2 retroviral vector containing a FLAG-tagged mouse S1P1, IRES, 
and a truncated human CD4 (hCD4) has been previously described (Lo 
et al., 2005). MSCV2.2 vector constructs containing FLAG-tagged mouse 
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